Toni Richey, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2231 W Gentry Pkwy, Tyler, TX 75702 Phone: 903-535-9041 Fax: 903-787-5098 |
Joyce Daniel, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 928 N Glenwood Blvd, Tyler, TX 75702 Phone: 903-535-9041 |
Jennifer Boynton, FNP, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4293 Kinsey Dr, Tyler, TX 75703 Phone: 903-592-5670 Fax: 903-363-9207 |
Alexandra Dionne Kittrell, APRN, MSN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 825 Medical Dr Ste A, Tyler, TX 75701 Phone: 903-758-2610 Fax: 903-758-7081 |
Mrs. Marissa Ann Kuykendall, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 928 N Glenwood Blvd, Tyler, TX 75702 Phone: 903-535-9041 |
News Archive
The Johns Hopkins University School of Medicine and the Salk Institute for Biological Studies will co-lead a $15.4 million effort to develop new systems for quickly screening libraries of drugs for potential effectiveness against schizophrenia and bipolar disorder, the National Institute of Mental Health (NIMH) has announced.
Playing an active role in their radiation treatment decisions leaves cancer patients feeling more satisfied with their care, and may even relieve psychological distress around the experience, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the journal Cancer.
Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.
Another set of conjoined twins are expected to be born this week in Canada.
MabCure, Inc., a biotechnology company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has reached another development milestone, with the creation of its MAbs against Colorectal Cancer (CRC). After further characterization the company plans to explore the utility of these MAbs in terms of both the early diagnosis of CRC (in blood or feces specimens), as well as imaging agents for detecting micrometastatic disease during surgery and the detection of cancerous polyps during colonoscopy.
› Verified 8 days ago